osteoporosis

Bone Drugs Need Label Changes on Use Duration, Panel Says

Bone Drugs Need Label Changes on Use Duration, Panel Says

Bloomberg

FDA Panel Considers Bone-Drug Safety

FDA Panel Considers Bone-Drug Safety

WSJ Online

US judge narrows benchmark Fosamax case vs. Merck

US judge narrows benchmark Fosamax case vs. Merck

Reuters

FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk

FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk

Bloomberg

Tarsa gets more financing for oral osteoporosis drug

Tarsa gets more financing for oral osteoporosis drug

Bizjournals.com

Emisphere Receives Notice Of Results From Novartis For Oral PTH

Emisphere Receives Notice Of Results From Novartis For Oral PTH

BioMed Reports

Radius lands $91M, plans listing as it executes Ph3 osteoporosis drug trial

Radius lands $91M, plans listing as it executes Ph3 osteoporosis drug trial

Fierce Biotech

Long-Term Data on Amgen's Prolia

Long-Term Data on Amgen's Prolia

Yahoo/Zacks.com

News

Bone Drugs by Merck, Roche, Novartis May Add Leg Fractures

Bloomberg

News

Merck Wins First Fosamax ‘Jaw Death’ State-Court Trial

Bloomberg